These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26184052)

  • 1. Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury.
    Nance E; Porambo M; Zhang F; Mishra MK; Buelow M; Getzenberg R; Johnston M; Kannan RM; Fatemi A; Kannan S
    J Control Release; 2015 Sep; 214():112-20. PubMed ID: 26184052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia.
    Nemeth CL; Drummond GT; Mishra MK; Zhang F; Carr P; Garcia MS; Doman S; Fatemi A; Johnston MV; Kannan RM; Kannan S; Wilson MA
    Nanomedicine; 2017 Oct; 13(7):2359-2369. PubMed ID: 28669854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.
    Zhang Z; Lin YA; Kim SY; Su L; Liu J; Kannan RM; Kannan S
    J Neuroinflammation; 2020 Oct; 17(1):319. PubMed ID: 33100217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation.
    Zhang F; Nance E; Alnasser Y; Kannan R; Kannan S
    J Neuroinflammation; 2016 Mar; 13(1):65. PubMed ID: 27004516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics.
    Sharma A; Liaw K; Sharma R; Zhang Z; Kannan S; Kannan RM
    Theranostics; 2018; 8(20):5529-5547. PubMed ID: 30555562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation.
    Sharma R; Kim SY; Sharma A; Zhang Z; Kambhampati SP; Kannan S; Kannan RM
    Bioconjug Chem; 2017 Nov; 28(11):2874-2886. PubMed ID: 29028353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.
    Arteaga Cabeza O; Zhang Z; Smith Khoury E; Sheldon RA; Sharma A; Zhang F; Slusher BS; Kannan RM; Kannan S; Ferriero DM
    Neurobiol Dis; 2021 Jan; 148():105201. PubMed ID: 33271328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
    Kannan S; Dai H; Navath RS; Balakrishnan B; Jyoti A; Janisse J; Romero R; Kannan RM
    Sci Transl Med; 2012 Apr; 4(130):130ra46. PubMed ID: 22517883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.
    Mishra MK; Beaty CA; Lesniak WG; Kambhampati SP; Zhang F; Wilson MA; Blue ME; Troncoso JC; Kannan S; Johnston MV; Baumgartner WA; Kannan RM
    ACS Nano; 2014 Mar; 8(3):2134-47. PubMed ID: 24499315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.
    Wang B; Navath RS; Romero R; Kannan S; Kannan R
    Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome.
    Nance E; Kambhampati SP; Smith ES; Zhang Z; Zhang F; Singh S; Johnston MV; Kannan RM; Blue ME; Kannan S
    J Neuroinflammation; 2017 Dec; 14(1):252. PubMed ID: 29258545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture.
    Alnasser Y; Kambhampati SP; Nance E; Rajbhandari L; Shrestha S; Venkatesan A; Kannan RM; Kannan S
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29702566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12 Gene Therapy Ameliorates Ischemia-Induced White Matter Injury in Mouse Brain.
    Li Y; Tang G; Liu Y; He X; Huang J; Lin X; Zhang Z; Yang GY; Wang Y
    Stem Cells Transl Med; 2015 Oct; 4(10):1122-30. PubMed ID: 26253714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
    Serdar M; Herz J; Kempe K; Lumpe K; Reinboth BS; Sizonenko SV; Hou X; Herrmann R; Hadamitzky M; Heumann R; Hansen W; Sifringer M; van de Looij Y; Felderhoff-Müser U; Bendix I
    Brain Behav Immun; 2016 Feb; 52():106-119. PubMed ID: 26456693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsy.
    Zhang F; Zhang Z; Alt J; Kambhampati SP; Sharma A; Singh S; Nance E; Thomas AG; Rojas C; Rais R; Slusher BS; Kannan RM; Kannan S
    J Control Release; 2023 Jun; 358():27-42. PubMed ID: 37054778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia.
    Han L; Cai W; Mao L; Liu J; Li P; Leak RK; Xu Y; Hu X; Chen J
    Stroke; 2015 Sep; 46(9):2628-36. PubMed ID: 26243225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens.
    Carty ML; Wixey JA; Colditz PB; Buller KM
    Int J Dev Neurosci; 2008 Aug; 26(5):477-85. PubMed ID: 18387771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal Dexamethasone Treatment Exacerbates Hypoxia/Ischemia-Induced White Matter Injury.
    Yeh C-; Yeh CM; Yu TH; Chang KH; Huang CC; Hsu KS
    Mol Neurobiol; 2017 Nov; 54(9):7083-7095. PubMed ID: 27796747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury.
    Sharma R; Kambhampati SP; Zhang Z; Sharma A; Chen S; Duh EI; Kannan S; Tso MOM; Kannan RM
    J Control Release; 2020 Jul; 323():361-375. PubMed ID: 32339548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.
    Sharma A; Porterfield JE; Smith E; Sharma R; Kannan S; Kannan RM
    J Control Release; 2018 Aug; 283():175-189. PubMed ID: 29883694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.